Materials for modulating biological responses and methods of making
View Patent ↗A polymeric composition capable of releasing nitric oxide and modulating biological responses comprises a biocompatible polymer and S-nitrosated thiol bonded to the biocompatible polymer. The polymeric composition can have a thiol conversion of at least 40%. The polymeric composition can also have a nitric oxide recovery of at least 40% when under thermal decomposition conditions.
1. A method of forming a nitric oxide releasing biocompatible polymer for modulating biological response, the method comprising:
a. activating carboxyl groups of a biocompatible polymer in a non-aqueous solution by reaction with N-hydroxysuccinimide; and
b. converting thiol residues on the biocompatible polymer to S-nitrosated residues under non-aqueous conditions, wherein at least about 40% of thiol residues are converted to S-nitrosated residues.
2. The method of claim 1 , wherein the nitric oxide releasing biocompatible polymer comprises at least about 0.1 mmol of nitric oxide per 1 gram of the nitric oxide releasing biocompatible polymer.
3. The method of claim 1 , wherein the nitric oxide releasing biocompatible polymer comprises at least about 0.4 mmol of nitric oxide per 1 gram of the nitric oxide releasing biocompatible polymer.
4. The method of claim 1 , wherein the method further comprises forming the biocompatible polymer into a nanofiber after converting the thiol residues.
5. The method of claim 1 , wherein the S-nitrosated residues are residues from at least one member selected from the group consisting of: cysteamine, cysteine, and homocysteine.
6. The method of claim 1 , wherein the biocompatible polymer comprises a member selected from the group consisting of: polylactide, polyglycolide, poly(lactide-co-glycolide), poly(ε-caprolactone), chitosan and dextran.
7. The method of claim 1 , wherein the biocompatible polymer comprises poly(lactide-co-glycolide).
8. The method of claim 7 , wherein the S-nitrosated residues include residues from cysteamine.
9. The method of claim 7 , wherein the S-nitrosated residues include residues from cysteine.
10. The method of claim 7 , wherein the S-nitrosated residues include residues from homocysteine.
11. The method of claim 1 , wherein the biocompatible polymer comprises poly(lactic-co-glycolic-co-hydroxymethyl propionic acid).
12. The method of claim 1 , wherein the biocompatible polymer comprises dextran.
13. The method of claim 12 , wherein the S-nitrosated residues include residues from cysteine.
14. The method of claim 12 , wherein the S-nitrosated residues include residues from cysteamine.
15. The method of claim 1 , wherein the biocompatible polymer comprises chitosan.
16. The method of claim 1 , wherein the biocompatible polymer comprises dextran and poly(lactic-co-glycolic-co-hydroxymethyl propionic acid).